Brief: Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma

Infinity Pharmaceuticals

24/07/2023 14:43

July 24 (Reuters) - Infinity Pharmaceuticals Inc
 INFI.O :
    * INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER
AGREEMENT WITH MEI PHARMA
    * INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY
VALUE
DRIVER FOR INFINITY
    * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE
STRATEGIC
ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS
    * INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE
STRATEGIC
ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS
    * INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE
STRATEGIC
ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS
    * INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT
TEAM
EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES
    * INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION
OF
MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1
MILLION FROM MEI
    * INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO
RECEIVE
AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN
CIRCUMSTANCES
    * INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND
MANAGEMENT
TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

Source text for Eikon:  ID:nBwbp5JDTa 
Further company coverage:  INFI.O 

 ((Reuters.Briefs@thomsonreuters.com;))